Literature DB >> 2911016

Binding of monomeric and aggregated immunoglobulin to enzymes. A source of artefact in antibody assays.

B P O'Hara1, J Pyle, D McCarthy, J R Archer.   

Abstract

Pepsinogen has previously been shown to bind non-specifically to immune complexes and aggregated immunoglobulins. We demonstrate here using a solid-phase immunoassay that immunoglobulins aggregated by heat or glutaraldehyde bind non-specifically to several different enzymes. Some of these, including pepsinogen (marketed as pepsin), hyaluronidase and trypsin, are used in the breakdown of tissues or biochemical preparations during the preparation of antigens. Contamination of impure antigens by enzyme is likely to lead to products which bind non-specifically to immune complexes. This can cause misidentification of complexes as antibodies. We recommend that all tests for specific antibody involving the use of antigens prepared by these or other enzymes should include a control with aggregated immunoglobulin substituted for the test serum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911016     DOI: 10.1016/0022-1759(89)90201-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63.

Authors:  F Ukaji; I Kitajima; T Kubo; C Shimizu; T Nakajima; I Maruyama
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

2.  Immune complexes in ankylosing spondylitis.

Authors:  I L MacLean; J R Archer; M I Cawley; B L Kidd; B P O'Hara; F S Pegley; P W Thompson
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

3.  The panoramic picture of pepsinogen gene family with pan-cancer.

Authors:  Shixuan Shen; Hao Li; Jingwei Liu; Liping Sun; Yuan Yuan
Journal:  Cancer Med       Date:  2020-10-17       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.